323
Colossal Biosciences, founded in 2021, has become the Lone Star State’s first decacorn — which means the private company is valued at more than $10 billion.
It calls itself a ‘de-extinction’ company and made headlines when it announced it was working to bring back the woolly mammoth. Clickbait aside, Colossal believes its value lies in preserving species’ diversity and expanding its conservation efforts.
Colossal made history as the state’s first decacorn after securing $200 million in Series C funding. Read the full story in Dallas Innovates.
